Your browser doesn't support javascript.
loading
A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies.
Wang, Bo; Lin, Jun; Hoag, Matthew R; Wright, Meredith; Ma, Mingjun; Cai, Wenyan; Gallolu Kankanamalage, Sachith; Liu, Yue.
Afiliação
  • Wang B; Ab Studio, Inc., Hayward, CA 94545, USA.
  • Lin J; Genor Biopharma Co. Ltd., Shanghai 201203, P.R.C.
  • Hoag MR; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai 201203, P.R.C.
  • Wright M; Ab Studio, Inc., Hayward, CA 94545, USA.
  • Ma M; Ab Studio, Inc., Hayward, CA 94545, USA.
  • Cai W; Genor Biopharma Co. Ltd., Shanghai 201203, P.R.C.
  • Gallolu Kankanamalage S; Ab Studio, Inc., Hayward, CA 94545, USA.
  • Liu Y; Ab Studio, Inc., Hayward, CA 94545, USA.
Antib Ther ; 5(3): 216-225, 2022 Jul.
Article em En | MEDLINE | ID: mdl-36042698
The classical `knob-into-holes' (KIH) strategy (knob(T366Y)/hole (Y407T)) has successfully enhanced the heterodimerization of a bispecific antibody (BsAb) resulting in heterodimer formation up to 92% of protein A (ProA)-purified protein pool. However, it does not show high efficiency for every BsAb. KIH was initially applied to a CD20/CD3 BsAb. After in silico modeling, two additional new mutations, S354Y in knob-heavy chain (HC) and Q347E in hole-HC, together with KIH named `ETYY', were introduced in the Fc. The CD20/CD3 BsAb hybrid only represented ~ 50% of the ProA-purified protein pool when KIH was applied. With ETYY, the percentage of CD20/CD3 hybrid increased to 93.8%. CD20/CD3-v4b (containing ETYY) retains the original activity of the BsAb at both Fab and Fc regions, and also shows good developability. These results indicate that the computer-aided novel ETYY design has the potential to improve the development of next-generation BsAbs with higher yields and simpler purification.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antib Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antib Ther Ano de publicação: 2022 Tipo de documento: Article